Evidence map›Paper›PMID 40715029›Full record

ArticleCancer communications (London, England)2025

Coordinated gene expression within sustained STAT3-associated chromatin conformations contributes to hepatocellular carcinoma progression.

Sunyoung Jang, Sumin Yoon, Hyeokjun Yang, Nayun Choi, Su-Hyang Han, Lark Kyun Kim, Hyoung-Pyo Kim, Jong Hoon Park, Daeyoup Lee, Kyung Hyun Yoo

Abstract read
In one paragraph

Article in Cancer communications (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Crosstalk BetweenCancers · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sunyoung JangLaboratory of Biomedical Genomics, Department of Biological Sciences, Sookmyung Women's University, Seoul, Republic of Korea.
Sumin YoonLaboratory of Biomedical Genomics, Department of Biological Sciences, Sookmyung Women's University, Seoul, Republic of Korea.ORCID https://orcid.org/0009-0008-1638-8288
Hyeokjun YangDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
Nayun ChoiLaboratory of Biomedical Genomics, Department of Biological Sciences, Sookmyung Women's University, Seoul, Republic of Korea.
Su-Hyang HanLaboratory of Biomedical Genomics, Department of Biological Sciences, Sookmyung Women's University, Seoul, Republic of Korea.
Lark Kyun KimDepartment of Biomedical Sciences, Graduate School of Medical Science, Brain Korea 21 Project, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Hyoung-Pyo KimDepartment of Tropical Medicine, Institute of Tropical Medicine, Yonsei University College of Medicine, Seodaemun-gu, Seoul, Republic of Korea.
Jong Hoon ParkMolecular Medicine Lab, Department of Biological Sciences, Sookmyung Women's University, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0002-8082-0214
Daeyoup LeeDepartment of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
Kyung Hyun YooLaboratory of Biomedical Genomics, Department of Biological Sciences, Sookmyung Women's University, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0003-2172-5564

Funding

Korea Basic Science InstituteMinistry of Education of Korea RS-2024-00436674Ministry of Science and ICT, Korea 2022M3A9B6017424Ministry of Science and ICT, Korea 2022M3A9B6017654Ministry of Science and ICT, Korea 2023R1A2C1005868Ministry of Science and ICT, Korea NRF-2021R1A6A1A03038890National Research Facilities and Equipment CenterNational Research Foundation of Korea
6 · The paper itself

Abstract

backgroundPhosphorylated signal transducer and activator of transcription 3 (p-STAT3) has emerged as a critical modulator of hepatocellular carcinoma (HCC) progression. However, its role in three-dimensional (3D) chromatin conformation and the expression of genes linked to HCC aggressiveness remains largely unexplored. This study aimed to identify HCC 3D chromatin conformations that are regulated by sustained STAT3 activation and validate the molecular mechanisms underlying the aggressiveness of HCC.

methodsComparative analyses were performed using HCC cell lines with varying levels of STAT3 activation. Chromatin immunoprecipitation-sequencing (ChIP-seq) for p-STAT3 and H3K27ac was conducted to map p-STAT3-associated genomic regions and assess its influence on chromatin states. Chromatin conformation sequencings (high-throughput chromosome conformation capture and high-throughput chromosome conformation capture followed by immunoprecipitation) were employed to investigate the 3D genome landscape and identify conformational changes linked to sustained p-STAT3 activation. RNA-sequencing was performed to assess transcriptional changes in response to these chromatin rearrangements. Functional assays, including invasion and tube formation assays, were carried out to validate the phenotypic impact of p-STAT3 activation on HCC progressiveness. Pharmacological inhibition of STAT3 was tested to explore potential therapeutic avenues and resistance mechanisms.

resultsWe found that sustained activation of p-STAT3 was significantly associated with poor prognostic outcomes in HCC patients. ChIP-seq demonstrated that p-STAT3 regulated chromatin interactions, leading to the formation of frequently interacting regions (FIREs), stable structural units within the 3D genome. Genes within these p-STAT3-associated FIREs exhibited coordinated expression, with many involved in aggressiveness HCC phenotypes like invasion and tube formation. Chromatin conformation data indicated that these FIREs altered topologically associating domains (TADs), potentially influencing broader chromatin organization. Despite STAT3 inhibition, p-STAT3-associated chromatin conformations remained intact, maintaining the expression of genes within FIREs and contributing to drug resistance.

conclusionsSustained p-STAT3 activation significantly alters the 3D chromatin conformation in HCC, particularly through the formation of FIREs. These p-STAT3-associated FIREs drive the expression of genes involved in HCC aggressiveness and remain active despite STAT3-targeted treatments, suggesting a mechanism of drug resistance. These findings highlight the potential of targeting 3D chromatin dynamics as a therapeutic strategy in HCC, especially in cases of STAT3 inhibitor resistance.

Indexed as

Carcinoma, HepatocellularChromatinGene Expression Regulation, NeoplasticLiver NeoplasmsSTAT3 Transcription FactorCell Line, TumorChromatin Immunoprecipitation SequencingDisease ProgressionDrug Resistance, NeoplasmGene Knockdown TechniquesHumansMolecular ConformationNeoplasm InvasivenessSorafenibChromatinSorafenibSTAT3 protein, humanSTAT3 Transcription FactorCancer aggressivenessChromatin conformationHepatocellular carcinomaSTAT3

Identifiers

PMID40715029
PMCPMC12531425

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.